- Home
- EBS vs DGICB Comparison
EBS vs DGICB Comparison
Compare EBS & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBS | DGICB |
|---|---|---|
| Founded | 1998 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.3M | 562.0M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBS | DGICB |
|---|---|---|
| Price | $13.20 | $17.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 788.6K | 3.3K |
| Earning Date | 10-29-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | N/A | ★ 219.91 |
| EPS | 1.35 | ★ 2.38 |
| Revenue | $788,900,000.00 | ★ $987,826,105.00 |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | $15.21 | $3.46 |
| P/E Ratio | $9.51 | ★ $8.11 |
| Revenue Growth | N/A | ★ 0.89 |
| 52 Week Low | $4.02 | $13.19 |
| 52 Week High | $13.41 | $20.46 |
Technical Indicators
Market Signals| Indicator | EBS | DGICB |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 56.84 |
| Support Level | $12.02 | $15.96 |
| Resistance Level | $12.90 | $17.71 |
| Average True Range (ATR) | 0.50 | 0.32 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 75.00 | 79.80 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.